INTUITIVE SURGICAL INC (ISRG) Stock Fundamental Analysis
USA - NASDAQ:ISRG - US46120E6023 - Common Stock
552.23 USD
-12.41 (-2.2%)
550 USD
-2.23 (-0.4%)
We assign a fundamental rating of 7 out of 10 to ISRG. ISRG was compared to 188 industry peers in the Health Care Equipment & Supplies industry. ISRG gets an excellent profitability rating and is at the same time showing great financial health properties. ISRG is growing strongly while it is still valued neutral. This is a good combination! These ratings would make ISRG suitable for growth and quality investing!
1. Profitability
1.1 Basic Checks
ISRG had positive earnings in the past year.
In the past year ISRG had a positive cash flow from operations.
In the past 5 years ISRG has always been profitable.
ISRG had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
ISRG has a better Return On Assets (14.19%) than 95.74% of its industry peers.
ISRG's Return On Equity of 16.12% is amongst the best of the industry. ISRG outperforms 90.96% of its industry peers.
ISRG has a better Return On Invested Capital (14.96%) than 94.68% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ISRG is above the industry average of 8.98%.
The last Return On Invested Capital (14.96%) for ISRG is above the 3 year average (12.20%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.19% | ||
| ROE | 16.12% | ||
| ROIC | 14.96% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)12.2%
ROIC(5y)11.86%
1.3 Margins
ISRG has a better Profit Margin (28.58%) than 96.28% of its industry peers.
In the last couple of years the Profit Margin of ISRG has declined.
ISRG's Operating Margin of 29.44% is amongst the best of the industry. ISRG outperforms 97.34% of its industry peers.
In the last couple of years the Operating Margin of ISRG has declined.
ISRG has a better Gross Margin (66.38%) than 70.21% of its industry peers.
In the last couple of years the Gross Margin of ISRG has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 29.44% | ||
| PM (TTM) | 28.58% | ||
| GM | 66.38% |
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
2. Health
2.1 Basic Checks
ISRG has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, ISRG has more shares outstanding
The number of shares outstanding for ISRG has been increased compared to 5 years ago.
ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | N/A |
ROIC/WACC1.71
WACC8.77%
2.3 Liquidity
A Current Ratio of 4.97 indicates that ISRG has no problem at all paying its short term obligations.
With a decent Current ratio value of 4.97, ISRG is doing good in the industry, outperforming 79.26% of the companies in the same industry.
A Quick Ratio of 4.20 indicates that ISRG has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 4.20, ISRG is in the better half of the industry, outperforming 78.19% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.97 | ||
| Quick Ratio | 4.2 |
3. Growth
3.1 Past
ISRG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.12%, which is quite impressive.
Measured over the past years, ISRG shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.48% on average per year.
The Revenue has grown by 22.18% in the past year. This is a very strong growth!
ISRG shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.27% yearly.
EPS 1Y (TTM)28.12%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%30.43%
Revenue 1Y (TTM)22.18%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%22.91%
3.2 Future
Based on estimates for the next years, ISRG will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.47% on average per year.
Based on estimates for the next years, ISRG will show a quite strong growth in Revenue. The Revenue will grow by 14.12% on average per year.
EPS Next Y19.93%
EPS Next 2Y16.17%
EPS Next 3Y15.85%
EPS Next 5Y15.47%
Revenue Next Year21.17%
Revenue Next 2Y18.1%
Revenue Next 3Y16.53%
Revenue Next 5Y14.12%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 64.14, ISRG can be considered very expensive at the moment.
ISRG's Price/Earnings ratio is a bit cheaper when compared to the industry. ISRG is cheaper than 67.55% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 25.07. ISRG is valued rather expensively when compared to this.
ISRG is valuated quite expensively with a Price/Forward Earnings ratio of 55.82.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ISRG indicates a somewhat cheap valuation: ISRG is cheaper than 67.02% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 34.08. ISRG is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 64.14 | ||
| Fwd PE | 55.82 |
4.2 Price Multiples
ISRG's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ISRG is cheaper than 64.89% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ISRG is valued a bit cheaper than the industry average as 68.62% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 87.16 | ||
| EV/EBITDA | 54.95 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ISRG does not grow enough to justify the current Price/Earnings ratio.
ISRG has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ISRG's earnings are expected to grow with 15.85% in the coming years.
PEG (NY)3.22
PEG (5Y)5.59
EPS Next 2Y16.17%
EPS Next 3Y15.85%
5. Dividend
5.1 Amount
ISRG does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
552.23
-12.41 (-2.2%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners88.66%
Inst Owner Change3%
Ins Owners0.45%
Ins Owner Change1.04%
Market Cap197.96B
Revenue(TTM)9.61B
Net Income(TTM)2.75B
Analysts78.54
Price Target608.71 (10.23%)
Short Float %1.92%
Short Ratio2.8
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.16%
Min EPS beat(2)11.61%
Max EPS beat(2)18.71%
EPS beat(4)4
Avg EPS beat(4)13.53%
Min EPS beat(4)3.05%
Max EPS beat(4)20.76%
EPS beat(8)8
Avg EPS beat(8)11%
EPS beat(12)11
Avg EPS beat(12)7.6%
EPS beat(16)13
Avg EPS beat(16)5.75%
Revenue beat(2)2
Avg Revenue beat(2)2%
Min Revenue beat(2)1.84%
Max Revenue beat(2)2.17%
Revenue beat(4)4
Avg Revenue beat(4)2.55%
Min Revenue beat(4)1.09%
Max Revenue beat(4)5.12%
Revenue beat(8)5
Avg Revenue beat(8)1.17%
Revenue beat(12)6
Avg Revenue beat(12)0.55%
Revenue beat(16)8
Avg Revenue beat(16)0.31%
PT rev (1m)1.89%
PT rev (3m)1.63%
EPS NQ rev (1m)3.21%
EPS NQ rev (3m)3.33%
EPS NY rev (1m)5.63%
EPS NY rev (3m)9.92%
Revenue NQ rev (1m)1.65%
Revenue NQ rev (3m)1.69%
Revenue NY rev (1m)1.17%
Revenue NY rev (3m)1.34%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 64.14 | ||
| Fwd PE | 55.82 | ||
| P/S | 20.6 | ||
| P/FCF | 87.16 | ||
| P/OCF | 66.87 | ||
| P/B | 11.62 | ||
| P/tB | 11.86 | ||
| EV/EBITDA | 54.95 |
EPS(TTM)8.61
EY1.56%
EPS(NY)9.89
Fwd EY1.79%
FCF(TTM)6.34
FCFY1.15%
OCF(TTM)8.26
OCFY1.5%
SpS26.81
BVpS47.54
TBVpS46.57
PEG (NY)3.22
PEG (5Y)5.59
Graham Number95.97
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.19% | ||
| ROE | 16.12% | ||
| ROCE | 16.61% | ||
| ROIC | 14.96% | ||
| ROICexc | 29.62% | ||
| ROICexgc | 30.86% | ||
| OM | 29.44% | ||
| PM (TTM) | 28.58% | ||
| GM | 66.38% | ||
| FCFM | 23.63% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)12.2%
ROIC(5y)11.86%
ROICexc(3y)18.44%
ROICexc(5y)19.03%
ROICexgc(3y)19.29%
ROICexgc(5y)20.12%
ROCE(3y)13.54%
ROCE(5y)13.16%
ROICexgc growth 3Y-7.59%
ROICexgc growth 5Y-7%
ROICexc growth 3Y-6.87%
ROICexc growth 5Y-6.06%
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
F-Score8
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 111.36% | ||
| Cap/Sales | 7.17% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 85.84% | ||
| Profit Quality | 82.69% | ||
| Current Ratio | 4.97 | ||
| Quick Ratio | 4.2 | ||
| Altman-Z | N/A |
F-Score8
WACC8.77%
ROIC/WACC1.71
Cap/Depr(3y)197.35%
Cap/Depr(5y)162.98%
Cap/Sales(3y)12.27%
Cap/Sales(5y)10.16%
Profit Quality(3y)56.77%
Profit Quality(5y)75.99%
High Growth Momentum
Growth
EPS 1Y (TTM)28.12%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%30.43%
EPS Next Y19.93%
EPS Next 2Y16.17%
EPS Next 3Y15.85%
EPS Next 5Y15.47%
Revenue 1Y (TTM)22.18%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%22.91%
Revenue Next Year21.17%
Revenue Next 2Y18.1%
Revenue Next 3Y16.53%
Revenue Next 5Y14.12%
EBIT growth 1Y36.82%
EBIT growth 3Y8.76%
EBIT growth 5Y11.37%
EBIT Next Year40.01%
EBIT Next 3Y23.66%
EBIT Next 5Y20.46%
FCF growth 1Y80.69%
FCF growth 3Y-9.1%
FCF growth 5Y2.14%
OCF growth 1Y46.32%
OCF growth 3Y4.95%
OCF growth 5Y8.61%
INTUITIVE SURGICAL INC / ISRG FAQ
Can you provide the ChartMill fundamental rating for INTUITIVE SURGICAL INC?
ChartMill assigns a fundamental rating of 7 / 10 to ISRG.
Can you provide the valuation status for INTUITIVE SURGICAL INC?
ChartMill assigns a valuation rating of 4 / 10 to INTUITIVE SURGICAL INC (ISRG). This can be considered as Fairly Valued.
How profitable is INTUITIVE SURGICAL INC (ISRG) stock?
INTUITIVE SURGICAL INC (ISRG) has a profitability rating of 8 / 10.
What is the financial health of INTUITIVE SURGICAL INC (ISRG) stock?
The financial health rating of INTUITIVE SURGICAL INC (ISRG) is 7 / 10.